Physician profile
Hamid Ehsani-Shishvan
NPI 1720157647
$886.88
in general payments reported to CMS, 2019-2025
15 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $113 · 2022: $269 · 2023: $198 · 2024: $35.85 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.26 | 2020-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $161.41 | 2021-2024 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $96.97 | 2023 | |
| Alkermes, INC. | $75.04 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $55.51 | 2023 | Sotyktu |
| Eisai INC. | $49.60 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $47.34 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $44.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $39.18 | 2022 | |
| Arbor Pharmaceuticals, INC. | $30.87 | 2021 | |
| Currax Pharmaceuticals LLC | $27.09 | 2022 | |
| Horizon Therapeutics Plc | $21.73 | 2022 | |
| Sanofi Pasteur INC. | $14.28 | 2020 | |
| Phadia US INC. | $13.23 | 2020 | |
| Exact Sciences Corporation | $12.87 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Ehsani-Shishvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.